Results 51 to 60 of about 1,972,464 (129)

Bispecific antibodies (BsAb) and anti-CCP assay in mixing tests.

, 2013
(A) One anti-CCP-positive but BsAb-negative serum (#32) was mixed with different dilutions of one RF predominant serum (#3); concentrations of BsAb and anti-CCP in the mixtures were determined.
Jinming Li (128865), Wei Wang (17594)
core   +1 more source

Anti-cyclic citrullinated peptide antibodies – a role in rheumatoid arthritis and the possibility of seroconversion: A focus on abatacept

Современная ревматология, 2017
The detection of anti-cyclic citrullinated peptide (anti-CCP) antibodies plays a diagnostic and statistical predictive role in rheumatoid arthritis (RA).
N. V. Chichasova
doaj   +1 more source

Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: A pilot study [PDF]

, 2019
Objectives: To analyze the effects of tocilizumab on peripheral B-cell subpopulation and its ability to produce anti-cyclic citrullinated peptide (CCP) antibody in patients with rheumatoid arthritis (RA).
Toshiyuki Bohgaki (222986), Yasuda, Shinsuke, Masaru Kato (1298340), Miho Suzuki (207444), Yoshihiro Matsumoto (31279), Atsushi Noguchi (2986758), Ryo Hisada (6494081), Oku, Kenji, Tatsuya Atsumi (186298), Kenji Oku (2986761), Atsumi, Tatsuya, Kato, Masaru, Hisada, Ryo, Matsumoto, Yoshihiro, Bohgaki, Toshiyuki, Shinsuke Yasuda (2986755), Noguchi, Atsushi, Suzuki, Miho   +17 more
core   +1 more source

Cartilage Oligomeric Matrix Protein Associates Differentially with Erosions and Synovitis and Has a Different Temporal Course in Cyclic Citrullinated Peptide Antibody (Anti-CCP)-positive versus Anti-CCP-negative Early Rheumatoid Arthritis [PDF]

, 2011
Objective.Cyclic citrullinated peptide antibody (anti-CCP)-positive and anti-CCP-negative rheumatoid arthritis (RA) have been suggested as 2 distinctive disease subsets with respect to disease activity and prognosis. Previously, we proposed that anti-CCP
Jacobsen, Søren, Østergaard, Mikkel, Junker, Michael Peter, Lindegaard, Hanne, Ejbjerg, Bo Jannik, JENS K. PEDERSEN, Christensen, Anne F, Pedersen, Jens K, Svendsen, Anders, HENRIK SKJØDT, Pedersen, Jens K; id_orcid, Ostergaard, Mikkel, Pødenphant, Jan, Hansen, Ib, ULRIK TARP, SØREN JACOBSEN, ANDERS SVENDSEN, Junker, Peter, Hansen, Ib Tønder, TINE LOTTENBURGER, HANNE LINDEGAARD, KIM HØRSLEV-PETERSEN, BO EJBJERG, Andersen, Lis S, Ejbjerg, Bo, Skjødt, Henrik, JAN PØDENPHANT, PETER JUNKER, Ellingsen, Torkell Juulsgaad, Hetland, Merete Lund, Hørslev-Petersen, Kim, IB HANSEN, Ellingsen, Torkell Juulsgaad; id_orcid, Stengaard-Pedersen, Kristian, KRISTIAN STENGAARD-PEDERSEN, Lauridsen, Ulrik Birk, MERETE L. HETLAND, Lottenburger, Tine, ULRIK B. LAURIDSEN, Svendsen, Anders; id_orcid, ANNE F. CHRISTENSEN, MIKKEL ØSTERGAARD, Andersen, Lis Abildgaard, LIS S. ANDERSEN, Hetland, Merete L, TORKELL ELLINGSEN, Tarp, Ulrik, Lauridsen, Ulrik B   +47 more
core   +1 more source

Anti-CCP antibodies: A Better Diagnostic Tool for Rheumatoid Arthritis [PDF]

, 2009
Introduction: Rheumatoid factors are currently used in the diagnosis of rheumatoid arthritis and constitute one of the classification criteria proposed by the American College of Rheumatology. However, rheumatoid factor positivity shows low diagnostic
Hussin, Che Maraina Che
core   +1 more source

Is anti-cyclic citrullinated peptide antibody a good value biomarker for alzheimer disease?

International Journal of Preventive Medicine, 2013
Background: Alzheimer′s disease (AD) is one of the most important neurodegenerative disorder. Anti-cyclic citrullinated peptide (anti-CCP) may all be involved in the development of vascular disease such as AD.
Rokhsareh Meamar, Gholamreza Askari, Majid Ghasemi, Mohammad Reza Aghaye Ghazvini, Sahar Vesal, Mostafa Sharifkhah, Nazanin Alaei Faradonbeh   +6 more
doaj  

Anti-CCP antibodies are not associated with familial Mediterranean fever in childhood [PDF]

, 2013
Objective. Anticyclic citrullinated peptide antibodies (anti-CCP) testing is useful in the diagnosis of rheumatoid arthritis (RA) with high specificity. Arthritis is a very common clinical manifestation in children with familial Mediterranean fever (FMF).
Usta M., Bercem G., Onur H., Aral H., Kasapcopur Ö., Arica V.   +5 more
core   +2 more sources

The Influence of Polygenic Risk Scores on Heritability of Anti-CCP Level in RA [PDF]

, 2014
Objective: To study genetic factors that influence quantitative anti-cyclic citrullinated peptide (anti-CCP) antibody levels in RA patients. Methods: We carried out a genome wide association study (GWAS) meta-analysis using 1,975 anti-CCP+ RA patients ...
Lee, Yvonne Claire, Klareskog, Lars, Kallberg, H, Taylor, Kimberly E., Plenge, Robert M., Klareskog, L., Shadick, Nancy, Taylor, KE, Klareskog, L,, Coblyn, Jonathan, Shadick, NA, Kallberg, H., Gregersen, PK, Taylor, K. E., Cui, Jing, Weinblatt, ME, Gregersen, Peter K., Criswell, L. A., +2 additional authors, Karlson, E. W., Cui, J, Cui, J., Coblyn, J. S., Weinblatt, M. E., Criswell, LA, Gregersen, P. K., Källberg, Henrik, Lee, Y. C., Weinblatt, Michael, Karlson, Elizabeth, Criswell, Lindsey A., Lee, YC, Coblyn, JS   +32 more
core   +1 more source

Associação do anticorpo anticitrulina e gravidade da artrite reumatóide Association of anti-cyclic citrullinated peptide antibody and severe rheumatoid arthritis

Revista Brasileira de Reumatologia, 2006
OBJETIVOS: Avaliar a associação do anticorpo antipeptídeo citrulinado cíclico (anti-CCP) com distintos parâmetros clínicos, sorológicos e radiológicos.
Aldifran Ferreira da Silva, Afonso Napoleão Matos, Áurea Maria Santana Lima, Elízia Fernandes Lima, Maria Isabel Campos de Couto Correa, Edgar M. Carvalho   +5 more
doaj   +1 more source

Antikörper gegen cyclische citrullinierte Peptide (anti-CCP):Wertigkeit eines Markers im Verlauf der Rheumatoiden Arthritis

, 2008
Anti-CCP haben sich in der Diagnostik der RA als wichtiges Hilfsmittel etabliert. Wir untersuchten, ob die Bestimmung von anti-CCP auch eine Bedeutung in der Verlaufsbeurteilung der RA hat. Dazu analysierten wir 100 Patienten mit RA. 84 von 100 Patienten
Butenschön, A. (Annkathrin)
core   +2 more sources